AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1,000m, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, ...
AskBio has dosed the first participant in the second group of a Phase 1/2 trial of AB-1003, an experimental gene therapy for ...
Biotherapeutics announced promising preclinical results for its systemic RTNova platform. The platform has successfully delivered ...
In January of 2018, an anime adaptation of the manga was announced. The series is directed by Kenichi Suzuki and produced by Yuma Takahashi (trailer shown below). The series premiered on July 7th, ...
Include popular icons in your React projects easily with react-icons, which utilizes ES6 imports that allows you to include only the icons that your project is using. For example, to use an icon from ...
A family from Plymouth has launched a worldwide search for a lifesaving stem cell donor. Dad and husband Philip Charlesworth is living with stage 4 cutaneous T-cell lymphoma, an extremely rare ...
Chinese Researchers Find Bat Virus Enters Human Cells Via Same Pathway as COVID By Julie Steenhuysen and Nancy Lapid (Reuters) - A newly discovered bat coronavirus uses the same cell-surface ...
A new international study has for the first time identified unique subpopulations of fat cells. Researchers from Israel's Ben Gurion University (BGU) noted that the study could pave the way for ...
A new discovery from an international collaborative research team has solved the mystery of how cells turn on their recycling process and create ‘garbage bags’ to remove proteins. The study, published ...
A cancer therapy that uses genetically engineered immune cells, called CAR T-cells, has kept a person free of a potentially fatal nerve tumour for a record-breaking 18 years. “This is ...
Vue icons plus icons total 50000+, support Vue 3/Vue 2.7+, allowing you to easily import and use them directly in Vue projects. For example, to use an icon from Material Design, your import would be: ...